BB BIOTECH AG - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2016$10,141,000
-45.1%
528,1880.0%0.40%
-22.6%
Q4 2015$18,487,000
-67.5%
528,188
-14.6%
0.52%
-71.1%
Q3 2015$56,849,000
+4.6%
618,1880.0%1.80%
+22.4%
Q2 2015$54,326,000
+18.4%
618,1880.0%1.47%
+7.8%
Q1 2015$45,888,000
+32.6%
618,1880.0%1.37%
+21.9%
Q4 2014$34,619,000
+36.7%
618,188
+10.7%
1.12%
+8.9%
Q3 2014$25,319,000
+9.5%
558,1880.0%1.03%
-6.3%
Q2 2014$23,115,000
-31.6%
558,188
+14.3%
1.10%
-37.0%
Q1 2014$33,817,000
+14.9%
488,1880.0%1.74%
+10.9%
Q4 2013$29,423,000
+26.7%
488,188
+27.8%
1.57%
+24.5%
Q3 2013$23,219,000381,8861.26%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders